Multi-Society Endorsed Position Statement Affirms the Clinical Value of Non-Pneumatic Compression in Lymphedema Management

Dayspring is a wearable non-pneumatic compression system that integrates static compression, sequential gradient compression, and muscle activation to support mobility during treatment. It is ...
PharmiWeb

Global Pneumatic Compression Pumps for Lymphedema Market 2020 Industry Research, Segmentation, Key Players Analysis and Forecast to 2025

The research report titled Global Pneumatic Compression Pumps for Lymphedema Market Growth 2020-2025 added by MarketandResearch.biz exhibits detailed information and an overview of the key influential ...
Business Wire

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

Lymphedema is commonly caused by cancer treatments due to damage of the lymph system from the tumor itself, radiation treatment or the surgical removal of lymph nodes. About the Dayspring® System The ...
KSL

Medline and Devon Medical Products Form Exclusive U.S. Distribution Alliance to Provide Greater Access to Lymphedema and Arterial Compression Devices

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
Business Wire

Koya Medical Launches Dayspring® Lower Extremity Active Compression Treatments for Lymphedema and Venous Disorders

Centers for Medicare & Medicaid Services (CMS) issues new Healthcare Common Procedure Coding System (HCPCS) codes for Dayspring lower extremity active compression OAKLAND, Calif.--(BUSINESS ...
The Globe and Mail

Koya Medical Receives FDA Clearance for Dayspring Lite, Bringing Much-Needed Movement to People Beginning Compression Therapy to Treat Lymphedema and Venous Disease

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, received Food and Drug Administration (FDA ...